Bis(4-cyanophenyl)methanol
CAS: 134521-16-7
Ref. 3D-FB18691
1g | A consultar | ||
2g | A consultar | ||
5g | A consultar | ||
10g | A consultar | ||
500mg | A consultar |
Informação sobre produto
- 4,4'-(Hydroxymethylene)bisbenzonitrileBis(p-cyanophenyl)methanolCGP 44645
- 4,4'-(Hydroxymethanediyl)Dibenzonitrile
- 4,4'-Dicyanobenzhydrol
- 4,4′-(Hydroxymethylene)bis[benzonitrile]
- 4,4′-Methanolbisbenzonitrile
- 4-[(4-Cyanophenyl)(hydroxy)methyl]benzonitrile
- 4-[A-(4-Cyanophenyl)-Hydroxymethyl]-Benzonitrile
- 4-[a-(4-Cyanophenyl)-hydroxymethyl]-benzonitrile(ForLetrozole)
- 4-[alpha-(4-Cyanophenyl)hydroxymethyl]benzonitrile
- 4-[α-(4-Cyanophenyl)-hydroxymethyl]-benzonitrile ( For Letrozole )
- Ver mais sinónimos
- Benzonitrile, 4,4′-(hydroxymethylene)bis-
- Bis(p-cyanophenyl)methanol
- Cgp 44645
Bis(4-cyanophenyl)methanol (BPM) is a toxic substance that is metabolized by the liver to 4-cyanophenol (4CP). BPM is used in clinical pharmacology as a marker for hepatic uptake and metabolism. BPM has been shown to induce cancer in animal studies, but it has not been shown to have any effect on human tissues. The effect of BPM on cancer development may be due to its ability to inhibit estrogen synthesis.
BPM also inhibits the enzyme aromatase, which converts androstenedione into estrone, which is then converted into estradiol.
Bis(4-cyanophenyl)methanol has also been shown to reduce the effects of letrozole, a drug commonly used in the treatment of breast cancer.
The concentration of BPM in plasma after oral ingestion varies with gender; women have higher concentrations than men at all time points after ingestion.
Propriedades químicas
Consulta técnica sobre: 3D-FB18691 Bis(4-cyanophenyl)methanol
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.